Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
Sign Up to like & getrecommendations! Published in 2019 at "Nature Biomedical Engineering"
DOI: 10.1038/s41551-019-0375-6
Abstract: Checkpoint blockade therapy targeting the programmed-death ligand 1 (PD-L1) and its receptor programmed cell death 1 promotes T-cell-mediated immunosurveillance against tumours, and has been associated with marked clinical benefit in cancer patients. Antibodies against PD-L1… read more here.
Keywords: palmitoylation; enhances cell; inhibiting palmitoylation; palmitoylation enhances ... See more keywords